Results 101 to 110 of about 41,569 (168)

Genetic Advances in <i>Cannabis sativa</i> L.: A Review of Recent Progress and Future Directions. [PDF]

Plants (Basel)
Daundasekara KC, Thennakoon KP, Wickramasinghe JS, Woldesenbet S, Delhom C, Chandra S, Weerasooriya AD.   +6 more
europepmc   +1 more source

Knowledge, Attitudes, and Clinical Experience with Cannabinoid Therapies: A Cross-Sectional Survey of Rheumatologists. [PDF]

Mediterr J Rheumatol
Mougui A, Baba Z, Bouchti IE.
europepmc   +1 more source

Cannabinoid efficacy for pain: dose, chronicity and route. [PDF]

Front Neurosci
Ellioff KJ, Critz M, Stella N, Bruchas MR, Land BB.   +4 more
europepmc   +1 more source

Distinct contributions of mu opioid and CB2 cannabinoid receptors to neuroimmune and behavioral responses. [PDF]

Adv Drug Alcohol Res
Kibret B, Onaivi ES, Sharma V.
europepmc   +1 more source

Don't Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model. [PDF]

FASEB J
Murataeva N, Youkilis J, Rao Y, Straiker A.   +3 more
europepmc   +1 more source

Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis. [PDF]

Support Care Cancer
Creangă-Murariu I, Alexa-Stratulat T, Rusu MI, Chiru S, Dascalu C, Dobre CE, Tamba BI.   +6 more
europepmc   +1 more source

Selective CB₂ Agonist <i>JWH-133</i> Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. [PDF]

Pharmaceuticals (Basel)
Özcan SS, Yapar R, Değerli İ, Elmas L, Korkmaz M, Çakır M.   +5 more
europepmc   +1 more source

Might modulation of the endocannabinoid system provide a potential dual therapeutic strategy for osteoporosis and depression? [PDF]

Gen Psychiatr
Wei P, Zhao P, Gu Z, Yang M, Karasik D, Cheung CL, Zheng H.   +6 more
europepmc   +1 more source